Fuyujia Pharmaceutical

Chongqing Fuyujia Pharmaceutical Co., Ltd. was established in 2015. The company's predecessor was the OTC Market Sales Department of Chongqing Academy of Chinese Materia Medica (established in 2007). The company is located at No. 1 Milan Road, Nan'an District, Chongqing, with an operating area of over 5,000 square meters, including a warehouse area of over 3,000 square meters, an office area of over 1,000 square meters, and an employee canteen, dormitory, and parking lot totaling approximately 1,000 square meters. The company's main products include Chinese and Western patent medicines, Chinese medicinal materials, traditional Chinese medicine decoction pieces, medical devices, health food, etc., covering more than 4,000 varieties, among which more than 1,000 are exclusively distributed in the Chongqing region. There are more than 800 supplier manufacturers and more than 4,000 downstream customers. In 2015, Fuyujia established a chain business division. To coordinate with the company's strategic layout, the chain business division was registered as Chongqing Linli Pharmacy Chain Co., Ltd., to develop chain pharmacies and build its own high-quality terminals. Currently, there are 10 directly operated stores.
Chongqing Fuyujia Pharmaceutical Co., Ltd. is a service-oriented enterprise. We adhere to quality first, reputation-based development, and customer first. We are fully committed to building a modern pharmaceutical enterprise featuring "complete varieties, favorable prices, good service, and fast logistics." All work is centered on service, providing customers with a perfect procurement experience and eliminating worries. For customers, we earn low profits through high-quality service. For employees, we create a warm home through humanized management. Cooperation for win-win results.
In the next 5 years, the chain company will develop at a rate of no less than 12 stores per year to reach more than 100-200 stores, with annual sales per store of no less than 1.8 million yuan, total sales of 200-400 million yuan, and a target net profit of 20-40 million yuan. Franchise stores will develop at more than twice the rate of directly operated stores. The wholesale company will achieve an annual sales and profit growth target of more than 30%, with sales of 400-800 million yuan (including distribution), gross profit of 40-80 million yuan, and net profit of 20-40 million yuan within 5 years. The company will achieve comprehensive shareholding system reform, with outstanding employees and core teams holding shares, all employees sharing dividends, and gradually moving toward the capital market.